| Pack Size : | 10ml |
| Category: Antiinfective | It is a highly efficacious , broad spectrum fourth generation fluoroquinolone. The antibacterial activity of gatigloxacin results from inhibition of DNA gyrase (Topoisomerase 11) and Topoisomerase IV , the enzyme that plays a key role in partitioning of the chromosomal DNA during bacterial cell division. |
| Indications: | Treatment of bacterial conjunctivitis caused by susceptible strains of the following aerobic gram- positive and gram- negative bacteria such as S. aureus , S. epidermidis, S. pneumoniae, S. mitis, Comyebacterium propinquulm and Haemophillus influenzae. |
Dosage: | Days 1 and 2 : instill one drop every two hours in the effected eye(s) while awake, up to 8 times daily. Days 3 through 7: instill one drop up to four times daily while awake. | | Contraindications: | Hypersensitivity to gatifloxacin , to other quinolones or to any other components in this medication. |
| Special Precautions: | General : As with other antiinfectives, prolonged use may result in overgrowth of non susceptible organisms, including fungi. If superinfection occurs discontinue use and institute alternative therapy. Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis. |
| Side Effects: | The must frequently reported side effects in the overall study population wear conjunctivitis.These events occurred in approximately 5-10% of patients. Other reported reactions occurring in 1-4% of patients wear chemosis , conjunctival hemorrhage,dry eye, eye discharege, eye irritation, eye pain, eyelid edema , headache, red eye , reduced visual acuity and taste disturbance. |
| Purity : | Not less than 99%. |
© Health Biotech Limited. All Rights Reserved (Terms of Use)
